Genetic susceptibility to pulmonary tuberculosis in Cambodia

Tuberculosis

Volumn 84, Issue 1-2, 2004, Pages 76-81

  Goldfeld, Anne E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cambodia; Candidate gene polymorphisms; Genetic susceptibility; HLA; Tuberculosis

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN;

ANTIGEN SPECIFICITY; ASSOCIATION; BINDING AFFINITY; CAMBODIA; CELL ACTIVITY; CLONAL ANERGY; COMMUNITY CARE; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; ETHNOLOGY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEALTH PROGRAM; HLA SYSTEM; HOST; HUMAN; IMMUNE RESPONSE; INCIDENCE; LUNG TUBERCULOSIS; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROTEIN MOTIF; PROTEIN PURIFICATION; RISK ASSESSMENT; RURAL AREA; T LYMPHOCYTE;

EID: 0345830676     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2003.08.007     Document Type: Conference Paper

References (38)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. J Am Med Assoc 1999;282:677-86.
2. Rom W, Garay S. Tuberculosis. Philadelphia: Little Brown, Inc; 1996.
3. The HIV/AIDS/STD situation and the national response in the Kingdom of Cambodia. Cambodia: UNAIDS; 2000. p. 1-56.
4. Goldfeld AE. Congressional hunger caucus round table hearing on tuberculosis emergency, 1994.
5. National Health Policies and Strategies for Tuberculosis Control In the Kingdom of Cambodia 2001-2005. Phnom Penh, Cambodia: Kingdom of Cambodia, Ministry of Health, National Center for Tuberculosis and Leprosy Control (CENAT); 2001, 8pp.
6. Thim S, Goldfeld AE. Curing tuberculosis: a manual for developing communities. Boston, MA: Center for Blood Research, Inc; 2000.
7. Lurie MB, Abramson S, Heppleston AG. On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human-type tubercle bacilli and the nature resistance to tuberculosis. J Exp Med 1952;95: 119-34.
8. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993;178:2243-7.
9. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J. Mice that lack the Interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993;178: 1435-40.
10. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for BCG. Cell 1993;73:469-85.
11. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
12. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94:8093-98.
13. Stead WW. Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics? Int J Tuberc Lung Dis 2001;5:807-14.
14. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942;47: 549-74.
15. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis [see comments]. N Engl J Med 1990;322:422-7.
16. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-5.
17. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996;335:1956-61.
18. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-5.
19. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4.
20. Gao PS, Fujishima S, Mao XQ, Remus N, Kanda M, Enomoto T, Dake Y, Bottini N, Tabuchi M, Hasegawa N, Yamaguchi K, Tiemessen C, Hopkin JM, Shirakawa T, Kishi F. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000;58:74-6.
21. Ryu S, Park YK, Bai GH, Kim SJ, Park SN, Kang S. 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis 2000;4:577-80.
22. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999;189:1863-74.
23. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuberc Lung Dis 1998;79:83-9.
24. Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV. Tuberculosis and chronic hepatitis B virus infection in Africans and variation In vitamin D receptor gene. J Infect Dis 1999;179:721-4.
25. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355:618-21.
26. Selvaraj P, Narayanan PR, Reetha AM. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J Med Res 2000;111:172-9.
27. Bellamy RJ, Hill AV. Host genetic susceptibility to human tuberculosis. Novartis Found Symp 1998;217:3-13.
28. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis 2001;81:335-41.
29. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld AE. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002;3: 482-7.
30. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002;186:1463-8.
31. Kramnik I, Dietrich WF, Demant P, Bloom BR. Genetic control of resistance to experimental Infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2000;97:8560-5.
32. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, Sashidhar M, Rajaram K, Ramu S, Palanimurugan K, Paramasivan CN, Prabhakar R. Association of pulmonary tuberculosis and HLA in south India. Tubercle 1991;72:123-32.
33. Bothamley GH, Beck JS, Schreuder GM, D'Amaro J, de Vries RR, Kardjito T, Ivanyi J. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis 1989;159:549-55.
34. Khomenko AG, Litvinov VI, Chukanova VP, Pospelov LE. Tuberculosis in patients with various HLA phenotypes. Tubercle 1990;71:187-92.
35. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D, Cohen C, Yunis EJ. Association of an HLA-DQ allele with clinical tuberculosis. J Am Med Assoc 1998;279: 226-8.
36. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001;2:501-7.
37. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105: 1317-25.
38. Delgado JC, Baena A, Thim S, Goldfeld AE. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 2002;99:7576-81.